Mark A. Buthman's most recent trade in Idex Corporation was a trade of 895 COMMON STOCK done . Disclosure was reported to the exchange on May 8, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Idex Corporation | Mark A. Buthman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2025 | 895 | 9,220 (0%) | 0% | 0 | COMMON STOCK | |
| West Pharmaceutical Servic... | Mark A. Buthman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2025 | 1,071 | 42,860 (0%) | 0% | 0 | Common Stock | |
| Idex Corporation | Mark A. Buthman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2024 | 745 | 8,325 (0%) | 0% | 0 | COMMON STOCK | |
| West Pharmaceutical Servic... | Mark A. Buthman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Apr 2024 | 564 | 41,786 (0%) | 0% | 0 | Common Stock | |
| Idex Corporation | Mark A. Buthman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 770 | 7,580 (0%) | 0% | 0 | COMMON STOCK | |
| West Pharmaceutical Servic... | Mark A. Buthman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2023 | 616 | 41,222 (0%) | 0% | - | Common Stock | |
| West Pharmaceutical Servic... | Mark A. Buthman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 May 2022 | 632 | 40,606 (0%) | 0% | - | Common Stock | |
| Idex Corporation | Mark A. Buthman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 May 2022 | 825 | 6,810 (0%) | 0% | 0 | COMMON STOCK | |
| West Pharmaceutical Servic... | Mark A. Buthman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 53 | 10,831 | - | - | Phantom Stock Unit | |
| West Pharmaceutical Servic... | Mark A. Buthman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 63 | 10,778 | - | - | Phantom Stock Unit | |
| Idex Corporation | Mark A. Buthman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 665 | 5,985 (0%) | 0% | 0 | COMMON STOCK | |
| West Pharmaceutical Servic... | Mark A. Buthman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2021 | 577 | 39,974 (0%) | 0% | - | Common Stock | |
| West Pharmaceutical Servic... | Mark A. Buthman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 80 | 10,715 | - | - | Phantom Stock Unit |